Barely Significant
← all excerpts

Relationship between early use of tocilizumab during chimeric antigen receptor T-cell therapy for multiple myeloma and cardiovascular risk and progression-free survival.

Eur Heart J Open · 2026 · PMC13308710 · PMID 42368427

Europe PMCDOI
1
hedged sentence
0.0800
closest p · 1.6× alpha
0.0800
boldest claim

The sentences

did not reach statistical significanceP = 0.08so close (0.05 < p ≤ 0.1)
No MACEs occurred among patients who did not develop CRS, although the difference in MACE between patients who did and did not develop CRS did not reach statistical significance ( P = 0.08) ( Figure 1B ).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.